COVID-19 Impact on Global Seasonal Affective Disorder Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C6042E2B08AEEN
QYResearch

Abstracts

This report focuses on the global Seasonal Affective Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Seasonal Affective Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan
• Pfizer
• Roche
• Eli Lily
• GlaxoSmithKline
• Teva Pharmaceuticals
• Bausch Health Companies
• Mylan
• Sanofi
• Novartis
• Johnson & Johnson
• Koninklijke Philips
• Beurer GmbH
• Lucimed (Luminette)

Market segment by Type, the product can be split into

• Light Therapy (Phototherapy)
• Medication
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Seasonal Affective Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Seasonal Affective Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Seasonal Affective Disorder Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Seasonal Affective Disorder Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Light Therapy (Phototherapy)
  1.4.3 Medication
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Seasonal Affective Disorder Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Seasonal Affective Disorder Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Seasonal Affective Disorder Therapeutics Industry
    1.6.1.1 Seasonal Affective Disorder Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Seasonal Affective Disorder Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Seasonal Affective Disorder Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Seasonal Affective Disorder Therapeutics Market Perspective (2015-2026)
2.2 Seasonal Affective Disorder Therapeutics Growth Trends by Regions
  2.2.1 Seasonal Affective Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Seasonal Affective Disorder Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Seasonal Affective Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Seasonal Affective Disorder Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Seasonal Affective Disorder Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Seasonal Affective Disorder Therapeutics Players by Market Size
  3.1.1 Global Top Seasonal Affective Disorder Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Seasonal Affective Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio
  3.2.1 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Seasonal Affective Disorder Therapeutics Revenue in 2019
3.3 Seasonal Affective Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into Seasonal Affective Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2021-2026)

5 SEASONAL AFFECTIVE DISORDER THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
6.2 Seasonal Affective Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
7.2 Seasonal Affective Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
8.2 Seasonal Affective Disorder Therapeutics Key Players in China (2019-2020)
8.3 China Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
9.2 Seasonal Affective Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
10.2 Seasonal Affective Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
11.2 Seasonal Affective Disorder Therapeutics Key Players in India (2019-2020)
11.3 India Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Seasonal Affective Disorder Therapeutics Market Size (2015-2020)
12.2 Seasonal Affective Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview and Its Total Revenue
  13.1.3 Allergan Seasonal Affective Disorder Therapeutics Introduction
  13.1.4 Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Seasonal Affective Disorder Therapeutics Introduction
  13.2.4 Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Roche
  13.3.1 Roche Company Details
  13.3.2 Roche Business Overview and Its Total Revenue
  13.3.3 Roche Seasonal Affective Disorder Therapeutics Introduction
  13.3.4 Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.3.5 Roche Recent Development
13.4 Eli Lily
  13.4.1 Eli Lily Company Details
  13.4.2 Eli Lily Business Overview and Its Total Revenue
  13.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Introduction
  13.4.4 Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.4.5 Eli Lily Recent Development
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Details
  13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Introduction
  13.5.4 GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.5.5 GlaxoSmithKline Recent Development
13.6 Teva Pharmaceuticals
  13.6.1 Teva Pharmaceuticals Company Details
  13.6.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Introduction
  13.6.4 Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.6.5 Teva Pharmaceuticals Recent Development
13.7 Bausch Health Companies
  13.7.1 Bausch Health Companies Company Details
  13.7.2 Bausch Health Companies Business Overview and Its Total Revenue
  13.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Introduction
  13.7.4 Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.7.5 Bausch Health Companies Recent Development
13.8 Mylan
  13.8.1 Mylan Company Details
  13.8.2 Mylan Business Overview and Its Total Revenue
  13.8.3 Mylan Seasonal Affective Disorder Therapeutics Introduction
  13.8.4 Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.8.5 Mylan Recent Development
13.9 Sanofi
  13.9.1 Sanofi Company Details
  13.9.2 Sanofi Business Overview and Its Total Revenue
  13.9.3 Sanofi Seasonal Affective Disorder Therapeutics Introduction
  13.9.4 Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.9.5 Sanofi Recent Development
13.10 Novartis
  13.10.1 Novartis Company Details
  13.10.2 Novartis Business Overview and Its Total Revenue
  13.10.3 Novartis Seasonal Affective Disorder Therapeutics Introduction
  13.10.4 Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  13.10.5 Novartis Recent Development
13.11 Johnson & Johnson
  10.11.1 Johnson & Johnson Company Details
  10.11.2 Johnson & Johnson Business Overview and Its Total Revenue
  10.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Introduction
  10.11.4 Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  10.11.5 Johnson & Johnson Recent Development
13.12 Koninklijke Philips
  10.12.1 Koninklijke Philips Company Details
  10.12.2 Koninklijke Philips Business Overview and Its Total Revenue
  10.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Introduction
  10.12.4 Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  10.12.5 Koninklijke Philips Recent Development
13.13 Beurer GmbH
  10.13.1 Beurer GmbH Company Details
  10.13.2 Beurer GmbH Business Overview and Its Total Revenue
  10.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Introduction
  10.13.4 Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  10.13.5 Beurer GmbH Recent Development
13.14 Lucimed (Luminette)
  10.14.1 Lucimed (Luminette) Company Details
  10.14.2 Lucimed (Luminette) Business Overview and Its Total Revenue
  10.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Introduction
  10.14.4 Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020)
  10.14.5 Lucimed (Luminette) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Seasonal Affective Disorder Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Seasonal Affective Disorder Therapeutics Revenue
Table 3. Ranking of Global Top Seasonal Affective Disorder Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Light Therapy (Phototherapy)
Table 6. Key Players of Medication
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Seasonal Affective Disorder Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Seasonal Affective Disorder Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Seasonal Affective Disorder Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Seasonal Affective Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Seasonal Affective Disorder Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Seasonal Affective Disorder Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Seasonal Affective Disorder Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Seasonal Affective Disorder Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Seasonal Affective Disorder Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Seasonal Affective Disorder Therapeutics Players
Table 24. Global Seasonal Affective Disorder Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Seasonal Affective Disorder Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Seasonal Affective Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2019)
Table 27. Global Seasonal Affective Disorder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
Table 30. Date of Enter into Seasonal Affective Disorder Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Seasonal Affective Disorder Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Seasonal Affective Disorder Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Seasonal Affective Disorder Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 40. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 42. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 46. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 52. China Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 54. China Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 58. Japan Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 70. India Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 72. India Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Seasonal Affective Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Seasonal Affective Disorder Therapeutics Market Share (2019-2020)
Table 76. Central & South America Seasonal Affective Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Seasonal Affective Disorder Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Seasonal Affective Disorder Therapeutics Market Share by Application (2015-2020)
Table 80. Allergan Company Details
Table 81. Allergan Business Overview
Table 82. Allergan Product
Table 83. Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 84. Allergan Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Eli Lily Company Details
Table 96. Eli Lily Business Overview
Table 97. Eli Lily Product
Table 98. Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 99. Eli Lily Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Product
Table 103. GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 104. GlaxoSmithKline Recent Development
Table 105. Teva Pharmaceuticals Company Details
Table 106. Teva Pharmaceuticals Business Overview
Table 107. Teva Pharmaceuticals Product
Table 108. Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 109. Teva Pharmaceuticals Recent Development
Table 110. Bausch Health Companies Company Details
Table 111. Bausch Health Companies Business Overview
Table 112. Bausch Health Companies Product
Table 113. Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 114. Bausch Health Companies Recent Development
Table 115. Mylan Business Overview
Table 116. Mylan Product
Table 117. Mylan Company Details
Table 118. Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 119. Mylan Recent Development
Table 120. Sanofi Company Details
Table 121. Sanofi Business Overview
Table 122. Sanofi Product
Table 123. Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 124. Sanofi Recent Development
Table 125. Novartis Company Details
Table 126. Novartis Business Overview
Table 127. Novartis Product
Table 128. Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 129. Novartis Recent Development
Table 130. Johnson & Johnson Company Details
Table 131. Johnson & Johnson Business Overview
Table 132. Johnson & Johnson Product
Table 133. Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 134. Johnson & Johnson Recent Development
Table 135. Koninklijke Philips Company Details
Table 136. Koninklijke Philips Business Overview
Table 137. Koninklijke Philips Product
Table 138. Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 139. Koninklijke Philips Recent Development
Table 140. Beurer GmbH Company Details
Table 141. Beurer GmbH Business Overview
Table 142. Beurer GmbH Product
Table 143. Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 144. Beurer GmbH Recent Development
Table 145. Lucimed (Luminette) Company Details
Table 146. Lucimed (Luminette) Business Overview
Table 147. Lucimed (Luminette) Product
Table 148. Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2015-2020) (Million US$)
Table 149. Lucimed (Luminette) Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Seasonal Affective Disorder Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Light Therapy (Phototherapy) Features
Figure 3. Medication Features
Figure 4. Others Features
Figure 5. Global Seasonal Affective Disorder Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Seasonal Affective Disorder Therapeutics Report Years Considered
Figure 10. Global Seasonal Affective Disorder Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Seasonal Affective Disorder Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Seasonal Affective Disorder Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Seasonal Affective Disorder Therapeutics Market Share by Players in 2019
Figure 15. Global Top Seasonal Affective Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Seasonal Affective Disorder Therapeutics Revenue in 2019
Figure 17. North America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Allergan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 30. Eli Lily Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Eli Lily Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 34. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Teva Pharmaceuticals Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 36. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bausch Health Companies Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 38. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Mylan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 42. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Novartis Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Johnson & Johnson Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 46. Koninklijke Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Koninklijke Philips Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 48. Beurer GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Beurer GmbH Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 50. Lucimed (Luminette) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Lucimed (Luminette) Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed